Last 12 months
Inside the activity.
0 purchase rows · 202 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 39 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 42 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 10 |
| Jun 2026 | 0 | 18 |
| Jul 2026 | 0 | 20 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2018 Filed Jan 5, 2018 21:11 UTC |
SCHMERTZLER MICHAELDirector
|
GrantStock Option (Right To Buy) · Derivative | 28,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000020 · wf-form4_151518665065551.xml · derivative · entry 1 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2018 and vests over one year in twelve equal monthly installments, commencing on February 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:09 UTC |
Boulding Mark ElliottExec. VP and CLO
|
GrantStock Option (Right To Buy) · Derivative | 70,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000019 · wf-form4_151518657112093.xml · derivative · entry 1 Boulding Mark Elliott · CIK 0001578852 · Exec. VP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:15 UTC |
SOUTHWELL DAVID PDirector
|
GrantStock Option (Right To Buy) · Derivative | 14,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000022 · wf-form4_151518692149812.xml · derivative · entry 1 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2018 and vests over one year in twelve equal monthly installments, commencing on February 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:14 UTC |
Svoronos DawnDirector
|
GrantStock Option (Right To Buy) · Derivative | 14,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000021 · wf-form4_151518685616516.xml · derivative · entry 1 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2018 and vests over one year in twelve equal monthly installments, commencing on February 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:08 UTC |
Souza MarcioChief Operating Officer
|
GrantStock Option (Right To Buy) · Derivative | 2,696 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000017 · wf-form4_151518647228588.xml · derivative · entry 3 Souza Marcio · CIK 0001707657 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,696 Underlying: Common Stock · 2,696 shares Expires 2028-01-02 F3 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:08 UTC |
Souza MarcioChief Operating Officer
|
GrantStock Option (Right To Buy) · Derivative | 75,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000017 · wf-form4_151518647228588.xml · derivative · entry 2 Souza Marcio · CIK 0001707657 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-01-02 F3 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:08 UTC |
Souza MarcioChief Operating Officer
|
GrantCommon Stock | 1,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-18-000017 · wf-form4_151518647228588.xml · nonDerivative · entry 1 Souza Marcio · CIK 0001707657 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,742 F1 · shares: Restricted stock unit (RSU) award vests in four equal annual installments over four years, commencing on January 3, 2019. Upon vesting, each RSU will convert into one share of the issuer. F2 · balance_after: Includes 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:09 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
GrantStock Option (Right To Buy) · Derivative | 70,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000018 · wf-form4_151518652790156.xml · derivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-01-02 F4 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:09 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
GrantCommon Stock | 874 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-18-000018 · wf-form4_151518652790156.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,284 F1 · shares: Restricted stock unit (RSU) award vests in four equal annual installments over four years, commencing on January 3, 2019. Upon vesting, each RSU will convert into one share of the issuer. F2 · balance_after: Includes 1,060 shares acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2017 and 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:05 UTC |
Peltz Stuart WalterDirector · Chief Executive Officer
|
GrantStock Option (Right To Buy) · Derivative | 200,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000015 · wf-form4_151518633251741.xml · derivative · entry 1 Peltz Stuart Walter · CIK 0001578962 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:07 UTC |
Utter Christine MariePrincipal Financial Officer
|
GrantStock Option (Right To Buy) · Derivative | 40,000 | $0.00 Strike: $18.01 | $0.00 |
DisclosureSEC source: 0001070081-18-000016 · wf-form4_151518641813910.xml · derivative · entry 2 Utter Christine Marie · CIK 0001707685 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-01-02 F3 · derivative.exercise_date: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:25 UTC |
Utter Christine MariePrincipal Financial Officer
|
GrantStock Option (Right To Buy) · Derivative | 25,000 | $0.00 Strike: $13.10 | $0.00 |
DisclosureSEC source: 0001070081-17-000102 · wf-form4_149678789686726.xml · derivative · entry 2 Utter Christine Marie · CIK 0001707685 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-06-02 F1 · derivative.exercise_date: This option was granted on June 2, 2017, and vests over two years, with 50% of the shares underlying the option vesting on June 2, 2018, and an additional 12.5% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on September 2, 2018. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 22:54 UTC |
Souza MarcioChief Operating Officer
|
GrantStock Option (Right To Buy) · Derivative | 30,000 | $12.53 Strike: $12.53 | $375,900.00 |
DisclosureSEC source: 0001070081-17-000096 · wf-form4_149644405900854.xml · derivative · entry 2 Souza Marcio · CIK 0001707657 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2017-05-31 F2 · derivative.exercise_date: This option was granted on May 31, 2017, and vests in two equal annual installments over two years, commencing on May 31, 2018. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 22:54 UTC |
Souza MarcioChief Operating Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-17-000096 · wf-form4_149644405900854.xml · nonDerivative · entry 1 Souza Marcio · CIK 0001707657 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,457 F1 · shares: Restricted stock awarded to the Reporting Person vests in two equal annual installments over two years, commencing on May 31, 2018. Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:18 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionStock Option (Right To Buy) · Derivative | 2,000 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001070081-17-000090 · wf-form4_149574347356195.xml · derivative · entry 3 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,125 Underlying: Common Stock · 2,000 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on May 15, 2013 and vests as follows: 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014. Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:18 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionCommon Stock | 2,000 | $10.85 | $21,700.00 |
DisclosureSEC source: 0001070081-17-000090 · wf-form4_149574347356195.xml · nonDerivative · entry 1 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:17 UTC |
Svoronos DawnDirector
|
PurchaseCommon Stock | 25,000 | $13.49 | $337,230.00 |
DisclosureSEC source: 0001070081-17-000088 · wf-form4_149565705820885.xml · nonDerivative · entry 1 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Read SEC document |
| May 09, 2017 Filed May 11, 2017 21:20 UTC |
Kovacs Shane William CharlesChief Financial Officer
|
Exercise / conversionStock Option (Right To Buy) · Derivative | 10,000 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001070081-17-000086 · wf-form4_149453761648390.xml · derivative · entry 2 Kovacs Shane William Charles · CIK 0001579397 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,625 Underlying: Common Stock · 10,000 shares Expires 2023-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option award was granted on May 22, 2013, with 25% of the shares underlying the option vested on May 22, 2014, and an additional 2.083% of the original number of shares underlying the option vesting on a monthly basis thereafter, beginning on June 30, 2014. Read SEC document |
| May 09, 2017 Filed May 11, 2017 21:20 UTC |
Kovacs Shane William CharlesChief Financial Officer
|
Exercise / conversionCommon Stock | 10,000 | $10.85 | $108,500.00 |
DisclosureSEC source: 0001070081-17-000086 · wf-form4_149453761648390.xml · nonDerivative · entry 1 Kovacs Shane William Charles · CIK 0001579397 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2017 Filed May 3, 2017 00:09 UTC |
Complete Pharma Holdings II, LLC10% owner
|
OtherCommon Stock | 6,683,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-17-000733 · e616090_4-ptc.xml · nonDerivative · entry 1 Complete Pharma Holdings II, LLC · CIK 0001704768 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pro rata distribution of such common stock to those members of the reporting person that are "accredited investors" as defined in Regulation D promulgated under the Securities Act of 1933, as amended. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 20:42 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionStock Option (Right To Buy) · Derivative | 2,966 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001070081-17-000064 · wf-form4_148978335156475.xml · derivative · entry 3 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,227 Underlying: Common Stock · 2,966 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 20:42 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionCommon Stock | 2,966 | $10.85 | $32,181.10 |
DisclosureSEC source: 0001070081-17-000064 · wf-form4_148978335156475.xml · nonDerivative · entry 1 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 23:14 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionStock Option (Right To Buy) · Derivative | 3,125 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001070081-17-000053 · wf-form4_148737325111545.xml · derivative · entry 3 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,193 Underlying: Common Stock · 3,125 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 23:14 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionCommon Stock | 3,125 | $10.85 | $33,906.25 |
DisclosureSEC source: 0001070081-17-000053 · wf-form4_148737325111545.xml · nonDerivative · entry 1 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2017 Filed Jan 17, 2017 21:35 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionStock Option (Right To Buy) · Derivative | 3,125 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001070081-17-000051 · wf-form4_148468893986388.xml · derivative · entry 3 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,318 Underlying: Common Stock · 3,125 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014. Read SEC document |
| January 17, 2017 Filed Jan 17, 2017 21:35 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionCommon Stock | 3,125 | $10.85 | $33,906.25 |
DisclosureSEC source: 0001070081-17-000051 · wf-form4_148468893986388.xml · nonDerivative · entry 1 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 23:01 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
SaleCommon Stock | 78 | $11.82 | $921.96 |
DisclosureSEC source: 0001070081-17-000045 · wf-form4_148374368411152.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 2,687 F1 · kind: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 187 RSUs from a January 4, 2016 grant of 750 shares. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:25 UTC |
ZELDIS JEROME BDirector
|
GrantStock Option (Right To Buy) · Derivative | 12,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000041 · wf-form4_148366230507066.xml · derivative · entry 1 ZELDIS JEROME B · CIK 0001433982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 02:49 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
GrantStock Option (Right To Buy) · Derivative | 35,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000043 · wf-form4_148367095214228.xml · derivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-01-02 F4 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 02:49 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
GrantCommon Stock | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-17-000043 · wf-form4_148367095214228.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 2,765 F2 · shares: Restricted stock unit (RSU) award vests in four equal annual installments over four years, commencing on January 3, 2018. Upon vesting, each RSU will convert into one share of the issuer. F3 · balance_after: Includes 750 RSUs (previously reported in Table II), granted on January 4, 2016, which vest in equal installments over four years on each anniversary of the grant date. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 02:49 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-17-000043 · wf-form4_148367095214228.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F1 · shares: Restricted stock award vests in four equal annual installments over four years, commencing on January 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:25 UTC |
SCHMERTZLER MICHAELDirector
|
GrantStock Option (Right To Buy) · Derivative | 24,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000040 · wf-form4_148366228876599.xml · derivative · entry 1 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2027-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:24 UTC |
Renaud Ronald C JRDirector
|
GrantStock Option (Right To Buy) · Derivative | 12,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000039 · wf-form4_148366227250178.xml · derivative · entry 1 Renaud Ronald C JR · CIK 0001354434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:24 UTC |
Jacobson Allan StevenDirector
|
GrantStock Option (Right To Buy) · Derivative | 12,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000038 · wf-form4_148366225449037.xml · derivative · entry 1 Jacobson Allan Steven · CIK 0001579003 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:24 UTC |
Koppel AdamDirector
|
GrantStock Option (Right To Buy) · Derivative | 12,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000037 · wf-form4_148366223551992.xml · derivative · entry 1 Koppel Adam · CIK 0001578965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:23 UTC |
Svoronos DawnDirector
|
GrantStock Option (Right To Buy) · Derivative | 12,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000036 · wf-form4_148366221909135.xml · derivative · entry 1 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:23 UTC |
STEELE GLENN JR MD PHDDirector
|
GrantStock Option (Right To Buy) · Derivative | 12,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000035 · wf-form4_148366220139677.xml · derivative · entry 1 STEELE GLENN JR MD PHD · CIK 0001269131 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:23 UTC |
McDonough Cameron GeoffreyDirector
|
GrantStock Option (Right To Buy) · Derivative | 12,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000034 · wf-form4_148366218528315.xml · derivative · entry 1 McDonough Cameron Geoffrey · CIK 0001579130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:13 UTC |
Ong TuyenChief Medical Officer
|
GrantStock Option (Right To Buy) · Derivative | 35,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000025 · wf-form4_148366159127249.xml · derivative · entry 2 Ong Tuyen · CIK 0001673178 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:13 UTC |
Ong TuyenChief Medical Officer
|
GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-17-000025 · wf-form4_148366159127249.xml · nonDerivative · entry 1 Ong Tuyen · CIK 0001673178 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · shares: Restricted stock awarded to the Reporting Person vests in four equal annual installments over four years, commencing on January 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:13 UTC |
Peltz Stuart WalterDirector · Chief Executive Officer
|
GrantStock Option (Right To Buy) · Derivative | 126,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000024 · wf-form4_148366157478148.xml · derivative · entry 2 Peltz Stuart Walter · CIK 0001578962 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2027-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:13 UTC |
Peltz Stuart WalterDirector · Chief Executive Officer
|
GrantCommon Stock | 21,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-17-000024 · wf-form4_148366157478148.xml · nonDerivative · entry 1 Peltz Stuart Walter · CIK 0001578962 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,876 F1 · shares: Restricted stock awarded to the Reporting Person vests in four equal annual installments over four years, commencing on January 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:12 UTC |
Rothera MarkChief Commercial Officer
|
GrantStock Option (Right To Buy) · Derivative | 56,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000023 · wf-form4_148366155839274.xml · derivative · entry 2 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Common Stock · 56,000 shares Expires 2027-01-02 F3 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:12 UTC |
Rothera MarkChief Commercial Officer
|
GrantCommon Stock | 9,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-17-000023 · wf-form4_148366155839274.xml · nonDerivative · entry 1 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,523 F1 · shares: Restricted stock awarded to the Reporting Person vests in four equal annual installments over four years, commencing on January 3, 2018. F2 · balance_after: Includes 1,707 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2016. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:12 UTC |
Kovacs Shane William CharlesChief Financial Officer
|
GrantStock Option (Right To Buy) · Derivative | 52,500 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000022 · wf-form4_148366154289045.xml · derivative · entry 2 Kovacs Shane William Charles · CIK 0001579397 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2027-01-02 F2 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:12 UTC |
Kovacs Shane William CharlesChief Financial Officer
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-17-000022 · wf-form4_148366154289045.xml · nonDerivative · entry 1 Kovacs Shane William Charles · CIK 0001579397 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,850 F1 · shares: Restricted stock awarded to the Reporting Person vests in four equal annual installments over four years, commencing on January 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:12 UTC |
Boulding Mark ElliottExec. VP and CLO
|
GrantStock Option (Right To Buy) · Derivative | 52,500 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000021 · wf-form4_148366152753914.xml · derivative · entry 2 Boulding Mark Elliott · CIK 0001578852 · Exec. VP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2027-01-02 F3 · derivative.exercise_date: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:12 UTC |
Boulding Mark ElliottExec. VP and CLO
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001070081-17-000021 · wf-form4_148366152753914.xml · nonDerivative · entry 1 Boulding Mark Elliott · CIK 0001578852 · Exec. VP and CLO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,034 F1 · shares: Restricted stock awarded to the Reporting Person vests in four equal annual installments over four years, commencing on January 3, 2018. F2 · balance_after: Includes 1,707 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2016. Read SEC document |
| January 03, 2017 Filed Jan 9, 2017 22:39 UTC |
SOUTHWELL DAVID PDirector
|
GrantStock Option (Right To Buy) · Derivative | 12,000 | $0.00 Strike: $11.23 | $0.00 |
DisclosureSEC source: 0001070081-17-000049 · wf-form4_148400154187189.xml · derivative · entry 1 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-01-02 F1 · derivative.exercise_date: This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017. Read SEC document |
| November 14, 2016 Filed Nov 14, 2016 22:38 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionStock Option (Right To Buy) · Derivative | 1,941 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001179110-16-031529 · edgar.xml · derivative · entry 3 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,443 Underlying: Common Stock · 1,941 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.